全文获取类型
收费全文 | 63088篇 |
免费 | 4874篇 |
国内免费 | 1736篇 |
专业分类
耳鼻咽喉 | 830篇 |
儿科学 | 1194篇 |
妇产科学 | 2213篇 |
基础医学 | 7987篇 |
口腔科学 | 1162篇 |
临床医学 | 6749篇 |
内科学 | 11684篇 |
皮肤病学 | 1193篇 |
神经病学 | 3923篇 |
特种医学 | 2702篇 |
外国民族医学 | 6篇 |
外科学 | 8485篇 |
综合类 | 4184篇 |
现状与发展 | 7篇 |
一般理论 | 11篇 |
预防医学 | 3371篇 |
眼科学 | 1392篇 |
药学 | 5308篇 |
20篇 | |
中国医学 | 1672篇 |
肿瘤学 | 5605篇 |
出版年
2023年 | 461篇 |
2022年 | 610篇 |
2021年 | 2127篇 |
2020年 | 1293篇 |
2019年 | 1613篇 |
2018年 | 1995篇 |
2017年 | 1515篇 |
2016年 | 1567篇 |
2015年 | 2326篇 |
2014年 | 2915篇 |
2013年 | 3395篇 |
2012年 | 4816篇 |
2011年 | 4690篇 |
2010年 | 2986篇 |
2009年 | 2619篇 |
2008年 | 3543篇 |
2007年 | 3552篇 |
2006年 | 3390篇 |
2005年 | 3128篇 |
2004年 | 2828篇 |
2003年 | 2709篇 |
2002年 | 2352篇 |
2001年 | 1845篇 |
2000年 | 1613篇 |
1999年 | 1338篇 |
1998年 | 566篇 |
1997年 | 479篇 |
1996年 | 424篇 |
1995年 | 392篇 |
1994年 | 362篇 |
1993年 | 247篇 |
1992年 | 709篇 |
1991年 | 583篇 |
1990年 | 533篇 |
1989年 | 494篇 |
1988年 | 438篇 |
1987年 | 431篇 |
1986年 | 364篇 |
1985年 | 300篇 |
1984年 | 232篇 |
1983年 | 193篇 |
1982年 | 114篇 |
1981年 | 123篇 |
1980年 | 106篇 |
1979年 | 207篇 |
1978年 | 165篇 |
1977年 | 110篇 |
1976年 | 116篇 |
1975年 | 106篇 |
1974年 | 99篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
31.
32.
33.
Lin-Chau Chang 《Yao wu shi pin fen xi = Journal of food and drug analysis.》2019,27(3):671-678
In order to improve access to costly biological treatments, a biosimilar pathway in the United States of America (USA) was enacted under the Biologics Price Competition and Innovation Act (BPCI Act) of 2009. The aim of the present study was to investigate how the health policy, the establishment of the biosimilar pathway, influenced related companies by studying their respective perspectives and strategies revealed in literatures and publicly available resources. Perspectives of companies reveal the points of concern for the biosimilar pathway, such as data requirements, patents, interchangeability, naming, and exclusivity. Innovator companies may utilize expedited programs for serious conditions, enhance patent protection, launch programs for life-cycle extension, and develop biosimilars as well. The biosimilar companies overcoming technical barriers might need to gather convincing evidence to facilitate market penetration as well as to distinguish their products from those of other biosimilar competitors. More challenges are expected for innovator companies if international harmonization takes place, which might be worth further investigation. 相似文献
34.
35.
36.
37.
目的研究煮炸鹿茸加工过程中晚期糖基化终产物的生成规律及动力学参数。方法通过构建葡萄糖与赖氨酸模拟煮炸鹿茸加工过程美拉德(Maillard)反应体系,分别采用紫外-可见分光光度法和UPLC-MS/MS法测定体系褐变指数和典型晚期糖基化终产物(羧甲基赖氨酸和羧乙基赖氨酸)含量变化,探讨晚期糖基化终产物的生成规律和动力学参数。结果鹿茸加工过程中煮炸时发生褐变反应,生成羧甲基赖氨酸和羧乙基赖氨酸反应的活化能分别为5.07、40.44、78.47 kJ/mol,且均为零级反应;烘烤时相应反应的活化能分别为6.72、89.34、164.77 kJ/mol,也均为零级反应。相对于生成羧甲基赖氨酸而言,生成羧乙基赖氨酸所需能量更高,反应更难发生。结论烘烤过程温度变化对晚期糖基化终产物的动力学参数影响显著高于煮炸过程,长时间较高温度的烘烤使鹿茸中产生了较多的晚期糖基化终产物,这些结果为鹿茸加工过程中晚期糖基化终产物的阻断、抑制策略提供了理论基础,对生产绿色安全的鹿茸及加强中药安全具有重要意义。 相似文献
38.
Ping Liu Jiang Peng Gong-Hai Han Xiao Ding Shuai Wei Gang Gao Kun Huang Feng Chang Yu Wang 《中国神经再生研究》2019,(8)
Resident and inflammatory macrophages are essential effectors of the innate immune system. These cells provide innate immune defenses and regulate tissue and organ homeostasis. In addition to their roles in diseases such as cancer, obesity and osteoarthritis, they play vital roles in tissue repair and disease rehabilitation. Macrophages and other inflammatory cells are recruited to tissue injury sites where they promote changes in the microenvironment. Among the inflammatory cell types, only macrophages have both pro-inflammatory(M1) and anti-inflammatory(M2) actions, and M2 macrophages have four subtypes. The co-action of M1 and M2 subtypes can create a favorable microenvironment, releasing cytokines for damaged tissue repair. In this review, we discuss the activation of macrophages and their roles in severe peripheral nerve injury. We also describe the therapeutic potential of macrophages in nerve tissue engineering treatment and highlight approaches for enhancing M2 cell-mediated nerve repair and regeneration. 相似文献
39.
The state of the mother''s immune system during pregnancy has an important role in fetal development and disruptions in the balance of this system are associated with a range of neurologic, neuropsychiatric and neurodevelopmental disorders. Epidemiological and clinical reports reveal various clues that suggest a possible association between developmental neuropsychiatric disorders and family history of immune system dysfunction. Over the past three decades, analogous increases have been reported in both the incidence of neurodevelopmental disorders and immune-related disorders, particularly allergy and asthma, raising the question of whether allergic asthma and characteristics of various neurodevelopmental disorders share common causal links. We used a mouse model of maternal allergic asthma to test this novel hypothesis that early fetal priming with an allergenic exposure during gestation produces behavioral deficits in offspring. Mothers were primed with an exposure to ovalbumin (OVA) before pregnancy, then exposed to either aerosolized OVA or vehicle during gestation. Both male and female mice born to mothers exposed to aerosolized OVA during gestation exhibited altered developmental trajectories in weight and length, decreased sociability and increased marble-burying behavior. Moreover, offspring of OVA-exposed mothers were observed to have increased serotonin transporter protein levels in the cortex. These data demonstrate that behavioral and neurobiological effects can be elicited following early fetal priming with maternal allergic asthma and provide support that maternal allergic asthma may, in some cases, be a contributing factor to neurodevelopmental disorders. 相似文献
40.
Maggie L. Westfal David C. Chang Cassandra M. Kelleher 《Journal of pediatric surgery》2019,54(1):140-144